AAAAAA
Results: 1-25/29
Authors:
Kabelitz, D
Citation: D. Kabelitz, Immunology, of growing clinical value, DEUT MED WO, 126(37), 2001, pp. 997-997
Authors:
Conrad, K
Steinmann, J
Kabelitz, D
Rieber, EP
Citation: K. Conrad et al., Clinical significance of autoantibodies, DEUT MED WO, 126(37), 2001, pp. 1005-1010
Authors:
Schaffner, G
Kabelitz, D
Citation: G. Schaffner et D. Kabelitz, Therapeutic monoclonal antibodies, DEUT MED WO, 126(30), 2001, pp. 851-856
Authors:
Schaffner, G
Kabelitz, D
Citation: G. Schaffner et D. Kabelitz, Approved monoclonal antibodies for in vivo diagnosis, DEUT MED WO, 126(28-29), 2001, pp. 819-822
Authors:
Hinz, T
Weidmann, E
Kabelitz, D
Citation: T. Hinz et al., Dual TCR-expressing T lymphocytes in health and disease, INT A AL IM, 125(1), 2001, pp. 16-20
Authors:
Stepczynska, A
Lauber, K
Engels, IH
Janssen, O
Kabelitz, D
Wesselborg, S
Schulze-Osthoff, K
Citation: A. Stepczynska et al., Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation, ONCOGENE, 20(10), 2001, pp. 1193-1202
Authors:
Kabelitz, D
Wesch, D
Citation: D. Kabelitz et D. Wesch, Role of gamma delta T-lymphocytes in HIV infection, EUR J MED R, 6(4), 2001, pp. 169-174
Authors:
Hinz, T
Flindt, S
Marx, A
Janssen, O
Kabelitz, D
Citation: T. Hinz et al., Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product, CELL SIGNAL, 13(5), 2001, pp. 345-352
Authors:
Weidmann, E
Boehrer, S
Chow, KU
Engels, K
Harder, L
Hinz, T
Janssen, O
Kriener, S
Rummel, MJ
Siebert, R
Kabelitz, D
Hansmann, ML
Hoelzer, D
Mitrou, PS
Citation: E. Weidmann et al., Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine, ONKOLOGIE, 24(2), 2001, pp. 162-164
Authors:
Tchikov, V
Winoto-Morbach, S
Kabelitz, D
Kronke, M
Schutze, S
Citation: V. Tchikov et al., Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis, J MAGN MAGN, 225(1-2), 2001, pp. 285-293
Authors:
Kabelitz, D
Glatzel, A
Wesch, D
Citation: D. Kabelitz et al., Antigen recognition by human gamma delta T lymphocytes, INT A AL IM, 122(1), 2000, pp. 1-7
Authors:
Janssen, O
Stocker, A
Sanzenbacher, R
Oberg, HH
Siddiqi, MA
Kabelitz, D
Citation: O. Janssen et al., Differential regulation of activation-induced cell death in individual human T cell clones, INT A AL IM, 121(3), 2000, pp. 183-193
Authors:
Herrnring, C
Reimer, T
Jeschke, U
Makovitzky, J
Kruger, K
Gerber, B
Kabelitz, D
Friese, K
Citation: C. Herrnring et al., Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors, HISTOCHEM C, 113(3), 2000, pp. 189-194
Authors:
Zavazava, N
Kabelitz, D
Citation: N. Zavazava et D. Kabelitz, Alloreactivity and apoptosis in graft rejection and transplantation tolerance, J LEUK BIOL, 68(2), 2000, pp. 167-174
Authors:
Weidmann, E
Hinz, T
Klein, S
Schui, DK
Harder, S
Kriener, S
Kabelitz, D
Hoelzer, D
Mitrou, PS
Citation: E. Weidmann et al., Cytotoxic hepatosplenic gamma delta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biological and clinical features, HAEMATOLOG, 85(10), 2000, pp. 1024-1031
Authors:
Janssen, O
Sanzenbacher, R
Kabelitz, D
Citation: O. Janssen et al., Regulation of activation-induced cell death of mature T-lymphocyte populations, CELL TIS RE, 301(1), 2000, pp. 85-99
Authors:
Kabelitz, D
Citation: D. Kabelitz, Role of apoptosis in cardiac allograft vasculopathy, Z KARDIOL, 89, 2000, pp. 21-23
Authors:
Weber-Arden, J
Wilbert, OM
Kabelitz, D
Arden, B
Citation: J. Weber-arden et al., V delta repertoire during thymic ontogeny suggests three novel waves of gamma delta TCR expression, J IMMUNOL, 164(2), 2000, pp. 1002-1012
Authors:
Hinz, T
Kabelitz, D
Citation: T. Hinz et D. Kabelitz, Identification of the T-cell receptor alpha variable (TRAV) gene(s) in T-cell malignancies, J IMMUNOL M, 246(1-2), 2000, pp. 145-148
Authors:
Luschen, S
Ussat, S
Scherer, G
Kabelitz, D
Adam-Klages, S
Citation: S. Luschen et al., Sensitization to death receptor cytotoxicity by inhibition of Fas-associated death domain protein (FADD)/caspase signaling - Requirement of cell cycle progression, J BIOL CHEM, 275(32), 2000, pp. 24670-24678
Authors:
Reimer, T
Herrnring, C
Koczan, D
Richter, D
Gerber, B
Kabelitz, D
Friese, K
Thiesen, HJ
Citation: T. Reimer et al., FasL : Fas ratio - A prognostic factor in breast carcinomas, CANCER RES, 60(4), 2000, pp. 822-828
Authors:
Hinz, T
Allam, A
Wesch, D
Schindler, D
Kabelitz, D
Citation: T. Hinz et al., Cell-surface expression of transrearranged V gamma-C beta T-cell receptor chains in healthy donors and in ataxia telangiectasia patients, BR J HAEM, 109(1), 2000, pp. 201-210
Authors:
Marget, M
Sharma, BB
Tesar, M
Kretzschmar, T
Jenisch, C
Westphal, E
Davarnia, P
Weiss, E
Ulbrecht, M
Kabelitz, D
Kronke, M
Citation: M. Marget et al., Bypassing hybridoma technology: HLA-C reactive human single-chain antibodyfragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities, TISSUE ANTI, 56(1), 2000, pp. 1-9
Authors:
Kabelitz, D
Citation: D. Kabelitz, Immunology: Realizable discoveries, DEUT MED WO, 124(51-52), 1999, pp. 1570-1572
Authors:
Kabelitz, D
Janssen, O
Citation: D. Kabelitz et O. Janssen, Antigen-induced death of T-lymphocytes, PEDIAT PATH, 18(4-5), 1999, pp. 329-354